1. Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11β-HSD1 inhibitors
- Author
-
Stefania Ursu, Daqing Sun, Yosup Rew, Juan C. Jaen, Jay P. Powers, Xiao He, Hua Tu, Dustin McMinn, and Michael DeGraffenreid
- Subjects
Stereochemistry ,Clinical Biochemistry ,Drug Evaluation, Preclinical ,Molecular Conformation ,Pharmaceutical Science ,Crystallography, X-Ray ,Transfection ,Biochemistry ,Piperazines ,11β hsd1 inhibitors ,Structure-Activity Relationship ,11-beta-Hydroxysteroid Dehydrogenase Type 1 ,Drug Discovery ,Humans ,Anilides ,Enzyme Inhibitors ,Piperazine ,Molecular Biology ,Biological evaluation ,chemistry.chemical_classification ,Sulfonamides ,Aniline Compounds ,Chemistry ,Organic Chemistry ,Combinatorial chemistry ,Sulfonamide ,Enzyme Activation ,HEK293 Cells ,Molecular Medicine ,hormones, hormone substitutes, and hormone antagonists - Abstract
A novel series of benzenesulfonanilide derivatives of 11β-HSD1 inhibitors were identified via modification of the sulfonamide core of the arylsulfonylpiperazine lead structures. The synthesis, in vitro biological evaluation, and structure–activity relationship of these compounds are presented. Optimization of this series rapidly resulted in the discovery of compounds (S)-10 and (S)-23 (11β-HSD1 SPA IC50 = 1.8 and 1.4 nM, respectively).
- Published
- 2012